Publication date: Jun 29, 2026
To investigate whether IgG to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens could reveal undetected SARS-CoV-2 exposure in a cohort of Malawian pregnant women participating in the REVAMP clinical trial. A secondary analysis of serological samples from a randomised controlled trial of iron supplementation in pregnancy, which began recruiting women in November 2018 and had its last visit occurring in September 2021. Resource-limited setting in Zomba and Blantyre, Southern Malawi. Pregnant women with ultrasound-confirmed singleton pregnancies in the second trimester, with haemoglobin
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | severe acute respiratory syndrome |
| drug | DRUGBANK | Iron |
| disease | MESH | COVID-19 |
| disease | MESH | INFECTIOUS DISEASES |
| disease | MESH | Pregnancy Complications Infectious |
Original Article
(Visited 6 times, 1 visits today)